Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer

Antzeko izenburuak

• Treatment of Non Small Cell Lung Cancer: Overcoming the resistance to EGFR inhibitors
  nork: Carter, Corey A., et al.
  Argitaratua: (2012)
• Novel Selective and Potent EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer
  nork: Li, Yanxia, et al.
  Argitaratua: (2016)
• Mimicking the BIM BH3 domain overcomes resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
  nork: Xia, Jinjing, et al.
  Argitaratua: (2017)
• Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer
  nork: Yochum, Zachary A., et al.
  Argitaratua: (2018)
• Clinical activity of the mutant-selective EGFR inhibitor AZD9291 in patients with EGFR inhibitor—resistant non-small cell lung cancer
  nork: Jiang, Tao, et al.
  Argitaratua: (2014)